Stux Capital Management’s AbbVie ABBV Stock Holding History

Stux Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$7.3M	Sell	129,400 -50,400	-28%	-$2.64M	0.95%	14
2014 Q1	$9.24M	Sell	179,800 -3,700	-2%	-$187K	1.14%	9
2013 Q4	$9.69M	Buy	183,500 +1,100	+0.6%	+$54.1K	1.15%	13
2013 Q3	$8.16M	Sell	182,400 -2,500	-1%	-$111K	1.08%	15
2013 Q2	$7.64M	Buy	+184,900	New	+$8.09M	0.96%	17

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stux Capital Management's ABBV Position: Q2 2014 in Review

Stux Capital Management reduced its AbbVie (ABBV) stake by 28% in Q2 2014, selling an estimated $2.64M and leaving 129,400 shares worth $7.3M. The position accounts for 0.95% of the portfolio, ranked #14.

Stux Capital Management first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. The position peaked at $9.69M in Q4 2013. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Stux Capital Management held 129,400 shares of AbbVie worth $7.3M as of Q2 2014.
Stux Capital Management sold 50,400 AbbVie shares in Q2 2014, an estimated $2.64M.
AbbVie made up 0.95% of Stux Capital Management's portfolio in Q2 2014, its #14 holding.
Stux Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
Stux Capital Management's AbbVie position peaked at $9.69M in Q4 2013.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.